KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Current Assets: 2010-2015

Historic Current Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $84.5 million.

  • Biocryst Pharmaceuticals' Current Assets fell 37.47% to $84.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $84.5 million, marking a year-over-year decrease of 37.47%. This contributed to the annual value of $89.3 million for FY2014, which is 112.11% up from last year.
  • Biocryst Pharmaceuticals' Current Assets amounted to $84.5 million in Q3 2015, which was down 21.09% from $107.1 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Current Assets ranged from a high of $138.2 million in Q2 2014 and a low of $33.5 million during Q2 2013.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Current Assets value was $81.4 million (recorded in 2015), while the average stood at $75.4 million.
  • Its Current Assets has fluctuated over the past 5 years, first slumped by 43.58% in 2012, then skyrocketed by 312.32% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Current Assets (Quarterly) stood at $52.9 million in 2011, then dropped by 20.58% to $42.0 million in 2012, then grew by 0.34% to $42.1 million in 2013, then skyrocketed by 112.11% to $89.3 million in 2014, then plummeted by 37.47% to $84.5 million in 2015.
  • Its Current Assets stands at $84.5 million for Q3 2015, versus $107.1 million for Q2 2015 and $81.4 million for Q1 2015.